A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether tricuspid valve (TV) repair with an annuloplasty ring leads to an improved outcome over a conventional suture annuloplasty for patients with severe tricuspid incompetence. Altogether, 306 papers were found using the reported search, of which 14 presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. We found seven studies supporting the use of ring annuloplasty over De Vega's suture annuloplasty. Five studies found no significant difference in outcome between the two techniques. We found only two studies supporting the use of De Vega's suture annuloplasty over ring annuloplasty. Therefore, most of the tabulated studies show good evidence in support of ring annuloplasty compared with De Vega's suture repair for treatment of moderate to severe TV regurgitation. One cohort study identified a 20.4% postoperative failure rate for tricuspid regurgitation (TR) repair and concluded non-application of ring as a predictor for reoperation. One cohort study with a mean follow-up of 17 months reported success rates as high as 97% with ring annuloplasty for TV regurgitation. One large cohort study of 2277 patients with TR who had undergone repair reported a sustained reduction in TR and the rate of recurrence in a 5-year echocardiographic follow-up. One cohort study of 129 patients concluded that ring annuloplasty has the lowest rate of recurrence compared with De Vega's suture repair. An old randomized controlled trial (RCT) on the subject also reported a similar result to the mentioned studies. In contrast, we reviewed one recent study and four older studies and found no significant difference between the two techniques. We reviewed one study that reported De Vega's suture repair as a superior technique to ring annuloplasty. We conclude that there is good evidence supporting ring annuloplasty over conventional De Vega's suture annuloplasty.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
CLINICAL SCENARIO
You are planning mitral valve repair on a 35-year old patient with severe mitral incompetence. He also has severe tricuspid regurgitation (TR) on echocardiography. It is your usual practice to perform a De Vega's suture tricuspid annuloplasty under these circumstances. However, a colleague tells you that, in his experience, people have now mostly moved away from suture annuloplasty towards commercially available annuloplasty rings as they are better. You decide to check the literature before switching to the more expensive option. 
THREE-PART QUESTION

SEARCH OUTCOME
Three hundred and six papers were identified from the search strategy from which 14 represented the best evidence on this topic and are summarized in Table 1 .
RESULTS
Moderate and severe TR is associated with poor short-and longterm survival [2] .
In the past few years, the treatment options for TR have ranged from conservative management to valve replacement and repair. However, recently, the management of TR has evolved in many ways shoulder to shoulder with the management of mitral incompetence, that is, from plication to suturebased annuloplasty to valve replacements and finally to state of the art ring-based repairs. Ring-based repairs are advantageous compared with the other mentioned techniques, since, theoretically, the artificial ring takes tension away from the suture line and prevents recurrent dilatation [3] . Hence, many studies now suggest an improved outcome with ring-based repairs over the conventional suture tricuspid annuloplasty [3] [4] [5] [6] [7] .
It is well known that residual TR after surgical repair can lead to biventricular failure, death or reoperation [8] , and therefore, the choice of repair is dictated predominantly by the recurrence rate of the procedure. The reported recurrence rates with De Vega's annuloplasty appear to be higher compared with ring repair [2, [4] [5] [6] [9] [10] [11] [12] . However, the only available randomized control trial on this issue is almost two decades old, when diagnosis of TR and its severity, both preoperatively and after, was on clinical grounds [13] .
Studies supporting ring annuloplasty as a treatment of choice for TR Bernal et al. [2] performed a retrospective cohort study with a 15-year follow-up. One hundred and fifty-three patients had undergone combined tricuspid and mitral valve repair surgery. Thirty-eight (20.4%) patients required reoperation for tricuspid valve (TV) dysfunction. The lack of application of an artificial ring was identified as a predictor for reoperation in this study. Ghoreishi et al. [9] performed a prospective cohort study of 101 consecutive patients who had undergone TV repair for TR with an annuloplasty ring. Freedom from more than moderate TR post-ring annuloplasty on discharge was as high as 97%. In a larger study, Navia et al. [10] studied a cohort of 2277 patients who had undergone TV procedures for TR. By the 5-year followup with transthoracic echocardiography, the patients who had undergone ring annuloplasty had the least TR recurrence compared with other techniques.
Basel et al. [12] performed a study of 129 patients undergoing annuloplasty for TR. Of this group, 67 had undergone ring annuloplasty and the remaining 62 patients had undergone De Vega's annuloplasty. The study concluded that ring annuloplasty has a significantly lower TR recurrent rate.
In our literature search, we only found one randomized controlled trial (RCT) with regard to the subject. This was performed by Rivera et al. [6] in 1985. One hundred and fifty-nine patients who had undergone TV repair for moderate to severe TR had been randomized, of which 76 patients had undergone ring annuloplasty and 83 De Vega's suture repair. The study concluded on the 5-year follow-up that the rate of TR was significantly higher with De Vega's suture repair compared with ring annuloplasty.
Matsuyama et al. [13] and Chang et al. [14] both also supported the above findings. However, the latter study compared pericardial strip annuloplasty with De Vega's suture annuloplasty.
Studies not supporting ring annuloplasty as treatment of choice for TR Giamberti et al. [3] , in a cohort of 65 patients who had undergone TR repair using suture annuloplasty (n = 48) and TV ring (n = 14), reported no significant difference in outcome between the two techniques on a 5-year follow-up. Moreover, Sarralde et al. [11] performed a retrospective cohort study of 299 patients who had undergone TV repair with a mean follow-up of 16.4 years. This study reported better results with the conventional De Vega's suture annuloplasty compared with ring annuloplasty.
Tang et al. [3] , Ghanta et al. [15] , McCarthy et al. [5] and Carrier et al. [16] found no statistically significant difference between the two techniques of ring annuloplasty and De Vega's annuloplasty.
Morishita et al. [17] reported in their cohort of 408 patients undergoing De Vega's annuloplasty that this is a safe and effective method of TR repair.
An important shortcoming central to almost all reported series is a non-standardized selection criterion for the repair technique that was based solely on the surgeon's discretion. This bias can only be overcome by a randomized trial, and it is unfortunate that none relevant to the current era is available.
A higher incidence of low cardiac output has been reported with ring annuloplasty [4] . We presume that this may arise as a consequence of a longer aortic cross-clamp time [3, 4] and bypass time [3] [4] [5] . In addition, a ring-based TV repair may be rendered less desirable by the relative inexpensiveness of a suture annuloplasty.
CLINICAL BOTTOM LINE
We conclude that there is good evidence to support ring annuloplasty over De Vega's annuloplasty. Multiple recent cohort studies support the use of ring annuloplasty for moderate to severe TR over De Vega's annuloplasty both in terms of the rate of recurrence of TR leading to reoperation and long-term mortality.
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